products of HLA loci. Yang et ai. (7) and Billing and Lucero (8) have both reported monoclonai antibodies (mAb) specific for all or most HLA-B-encoded gene products. Here, we show that a recently described (9) mAb, 131, recognizes a determinant unique to HLA-A locus-encoded proteins. Taken together, these data suggest that shared intralocus determinants, definable by mAb, do in fact exist in the human HLA system.
Materials and Methods
Cell Lines. Human cell lines were maintained at 37°C in RPMI-I640 supplemented with 10% fetal bovine serum (FBS), 25 mM Hepes, and 2 mM glutamine. All cell lines are B lymphoblastoid cell lines with the exception of Molt 4, a T cell line, and K562, an erythroleukemia cell line. The HLA-A,B type for each cell line is provided in Table I . Mouse L cells transfected with human class I genes were kindly provided by J. Barbosa (Harvard University, Cambridge, M A). The L cell transfectants were maintained at 37 °C in Dulbecco's a minimum essential medium supplemented with 10% FBS, 25 mM Hepes, and 2 mM glutamine. LJE1 has been transfected with the HLA-A2 and the human/32-m genes; LJG3 with HLA-B7 and human ~2-m; LB.40.10 with HLA-B40; and LJCM has been transfected only with the human 132-m gene (10) .
Antibodies. mAb 131 was produced in our lab and has been described before (9) ; it reacts with a subset of class I proteins. W6/32 (11) recognizes a nonpolymorphic determinant shared by all HLA class I gene products, mAb 4E, specific for all HLA-B gene products and HLA-A29, -A30, -A31, and -A32 (7), was kindly provided by S.-Y. Yang (Memorial Sloan-Kettering Cancer Center, New York); control antibody P3 was provided by M. Hemler (Harvard University). Mouse mAb PA2.1 (12) and BB7.1 (13) recognize allospecific determinants found on HLA-A2 and HLA-B7 gene products, respectively. mAb 187.1, a rat antibody specific for mouse ~ light chains, and which binds protein A, was grown from hybridoma cells obtained through the American Type Culture Collection, Rockville, MD. Rabbit antiserum raised against mouse F(ab) fragments was produced in our lab.
Cell-surface Binding Assays. Radioimmunoassays (RIA) to test mAb binding to cellsurface antigens were carried out at 4°C in phosphate buffered saline (PBS), pH 7.4, containing 1% FBS and 0.05% NaN~ (henceforth termed PBS-FBS-Az). Washed cells were plated in 96-well U-bottom plates at 105 cells/100 ~l/well. Antibodies were added (25/~l/well culture supernatants) and the plates were incubated for 1 h. After three washes 5 1251 in PBS-FBS-Az, 10 cpm/25 #i/well of I-labelled goat anti-mouse IgG,A,M was added, followed by another 1-h incubation. After five washes in PBS-FBS-Az, cells were harvested, and the number of counts bound was determined. In all cases, background radioactivity bound to cells in the absence of a primary mAb have been subtracted. Indirect immunofluorescence flow cytometry was carried out as described previously (9) . Cells were examined with a FACS IV fluorescence-activated cell sorter analyzer.
Protein Radiolabelling and lmmunoprecipitation. Cells (2-4 x 108 cells in 2 ml) were biosynthetically labelled in methionine-deficient medium (RPMI 1640 Met, Gibco Selectamine Kit; Gibco, Grand Island, NY) supplemented with 15% dialyzed FBS, 25 mM Hepes, 2 mM glutamine, and 250 #Ci/ml p~S]metbionine (Amersham Corp., Arlington Heights, I L). After a 12-18-h incubation at 37 °C, radiolabelled cells were washed twice in 10 ml ice-cold Hank's balanced salt solution. The cell pellets were suspended in icecold lysis buffer (1 ml of 10 mM Tris, pH 7.0, containing 1% Nonidet P-40 (NP-40), 10 mM iodoacetamide, and 1 mM phenylmethylsulfonylfluoride for 40 min after vigorous vortexing. The lysates were then centrifuged at 10,000 g for 10 min to remove cellular debris, and were dialyzed overnight against two changes of 40 mM NaCI in 10 mM Tris, pH 7.8.
Cell-surface proteins were labelled with ~I by the lactoperoxidase method (14) . 2-3 × 107 cells (>96% viable by Trypan Blue dye exclusion) were labelled, washed three times in 10 ml of PBS containing 2.1 gm KI per 100 ml, and lysed in 1 ml of 1% NP-40 in 10 mM Tris, and treated as described above.
Before immunoprecipitation, 1 ml of lysates were incubated with two cycles of heatinactivated, formalin-fixed Staphylococcus aureus (packed pellet from 250 ~1 of a 10% wt/vol suspension) and 20 ul of normal rabbit serum to remove nonspecifically bound proteins. Precleared lysates were used immediately or stored at -70°C. All steps were carried out at 4°C.
For immunoprecipitation, precleared lysates corresponding to 106 cells (250-500 #1) for 35S-labelled material, or 3-5 × 10 6 cells (100 #1) for 25I-labelled lysates were added to equal volumes of wash buffer (50 mM Tris, pH 7.8, 150 mM NaCI, 5 mM EDTA, 0.1% Az, 0.5% NP-40, 0.5% deoxycholic acid, 10% glycerol). Antibodies (2 ul ascites per sample) were added, followed by an overnight incubation. For mAb 131, rabbit antimouse F(ab) (25 #l) or 187.1 (10 ul ascites) was added to facilitate S. aureus binding. S. aureus (100 ul of a 10% wt/vol suspension) was added, followed by a 1-h incubation. Immune complexes were washed three times in 0.6 ml wash buffer. For isoelectric focusing (IEF), O'Farrell method (15) (see below), S. aureus pellets were resuspended in 40 IA IEF sample buffer, heated to 60°C for 15 min, and centrifuged. For IEF by the method of Krangel et al. (16), S. aureus pellets were resuspended in I00 ~1 of Laemmli's sample buffer, boiled for 2 rain, and centrifuged. Supernatants containing class I proteins were carefully removed and analyzed as described below.
Two-dimensional IEF Analysis.
Proteins were resolved according to the method of O'Farrell (15) . Briefly, class I antigens in 20 IA IEF sample buffer were separated in the first dimension by IEF using 2% ampholines (one part pH 3.5-10, two parts pH 4-6, two parts pH 6.8). After equilibrating the gels for 45 rain, proteins were further resolved in a second dimension by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12% polyacrylamide.
Proteins were also resolved as described by Krangel et al. (16) . Immunopurified class I antigens (50/A) were resolved by SDS-PAGE using 7.5% acrylamide according to Laemmli (17) . Using dansylated alcohol dehydrogenase (41 kD) as a molecular marker, the portion of the gel corresponding to 40-45 kD was excised, equilibrated, and polymerized into the IEF gel containing 2% ampholines (one part pH 3.5-10, one part pH 4-6, one part pH 6-8). Electrophoresis was carried out for 7 h at 1,000 V.
After electrophoresis, gels were fixed, enhanced (New England Nuclear, Boston, MA), and dried. Radioactive bands were detected by fluorography at -70°C using Kodak XR-5 film.
Results
Previous sequential immunoprecipitation and preclearing studies have shown that mAb 131, made against the human natural killer cell line 3.3, detects a subpopulation of class 1 molecules detected by the pan-HLA-reactive mAb W6/32 (9) . That mAb 131 detects only some of the class I proteins precipitated by W6/32 is further shown in Fig. 1 . Here, 125I-labelled JY (HLA-A2, B7) cell lysates were immunoprecipitated with a panel of class I-specific mAb and resolved on two-dimensional O'Farrell gels (15) . The results show that W6/32 reacts with both the HLA-A2 and HLA-B7 45 kD proteins (Fig. 1 A) , whereas 131 immunoprecipitates only the more basic HLA-A2 protein (Fig. 1B) . mAb 4E, which recognizes a determinant shared by all HLA-B locus proteins as well as HLA-A29, -A30, -A31, and -A32 proteins (7), reacts only with the more acidic HLA-B7 protein (Fig. 1 D) . The relative positions of the HLA-A2 and HLA-B7 spots were confirmed by analysis of proteins immunoprecipitated with mAb PA2.1 (anti-HLA-A2) (Fig. 1 C) and BB7.1 (anti-HLA-B7) (Fig. 1E) .
NK3.3, the immunizing cell line, andJY share the HLA-B7 allele, but express different HLA-A alleles, thus raising the possibility that mAb 131 may be specific for a number of different HLA-A locus-encoded gene products. To examine FIGURE 1. O'Farrell two-dimensional analysis of class I proteins immunoprecipitated with mAb W6/32, 131, PA2.1, 4E, and BBT.1. The first dimension is 1EF, with the basic end of the gel to the right. The second dimension is SDS-PAGE. The 12 kD spot, corresponding to /3~-m, has been aligned in all five gels. At 45 kD, the more basic HLA-A2 and the more acidic HLA-B7 spots can be seen when using W6132 (A). Only the more basic spot corresponding to HLA-A2 is seen when immunoprecipitating with 131 (B) or the HLA-A2-specific mAb, PA2.1 (C). The more acidic spot, corresponding to HLA-B7, can be seen with the HLA-B-specific mAb, 4E (D), or the HLA-B7°specific mAb, BB7.1 (E). Two-dimensional IEF analysis of class I antigens immunoprecipitated from [z~S]methionine-labelled NP-40 cell lysates. Samples were first resolved by SDS-PAGE. The region of the gel corresponding to 40-45 kD was excised, equilibrated, polymerized into the second (IEF) dimension, and furtber resolved. Gels were fixed and fluorographed for the detection of radioactive bands. For each radiolabelled cell line, lysates were divided into three aliquots and immunoprecipitated with 131, 4E, or W6/32. Cell lines are denoted at the top of the figure (see Table I for HLA typing). Major bands corresponding to the HLA alleles are designated. The gel is oriented with the basic end at the top of the figure. (Fig. 2) indicate that, for each of the different cell lines, the IEF banding profiles seen with 131 and 4E can be combined to produce the'W6/32 profile. Note also that mAb 131 and 4E, as expected, both react with HLA-A32 from MICH. From these data, we conclude that mAb 131 reacts with all of the HLA-A proteins tested (HLA-A2, -A3, -A9, -A24, -A28, and -A32), but not with the HLA-B proteins (HLA-B7,-B14,-B27, -B35, and -B40). Table I shows the cell-surface binding profiles of mAb 131 and W6/32, determined by RIA, on a panel of 19 human cell lines displaying 11 different HLA-A proteins and 12 different HLA-B proteins. As expected, 131 and W6/32 do not bind to Daudi and K562; neither cell line expresses class I proteins. All other cell lines bind both of these antibodies.
The specificity of mAb 131 for HLA-A2, and lack of reactivity with HLA-B7, -B40, and/~2-m is shown by FACS analysis of mouse L cell lines transfected with these genes (Fig. 3) . As expected, mAb W6/32, 131, and 4E bind to JY (A2 +, B7÷), W6/32 and 131 bind to LJE1 (A2+), W6/32 and 4E bind to LJG3 (B7 ÷) and LB.40. 
Discussion
The results presented above indicate that mAb 131 recognizes a determinant expressed on a number of different HLA-A proteins, mAb 131 is therefore a candidate for a pan-reactive HLA-A antibody, and to our knowledge, this is the first description of such an antibody. From IEF analysis, we have demonstrated that 131 reacts with HLA-A2, -A3, -A9, -A24, -A28, -A32, and -A33, and shows no apparent reactivity with HLA-B7, -B 14, -B27, -B35, and -B40 allelic products. Two HLA-B-specific mAb, 4E (7) (4E crossreacts with some HLA-A alleles), and 4G (8), have been reported. Cresswell and Ayres (18) produced rabbit antisera against purified HLA-A2 and -B7/-B12 antigens that displayed reactivity with other HLA-A and HLA-B alleles, respectively. These findings, along with our description of 131, provide serological evidence for the existence of some structural feature that distinguishes HLA-A and -B locus products. Evidence for such "A-ness" and "B-ness" is also supported at the molecular level. Arnot et al. (19) have recently described cDNA probes that define shared HLA intralocus sequences in class I mRNA. Whether such shared intralocus sequences correspond to epitopes detected by locus-specific mAb remains to be determined. The possibility of shared intralocus determinants raises questions concerning the molecular nature of these epitopes and what biological function, if any, they may have. We are now attempting to biochemically characterize the epitope seen by 131. mAb 131 reacts with isolated class I heavy chains in protein blots, but only under nonreducing conditions (B. Spear, J. Kornbluth, and D. Wilson, manuscript in preparation). It therefore appears that the structural integrity of the epitope defined by mAb 131 on class I heavy chains does not depend on association with/32-m, but intact intrachain disulfide bonds are necessary.
It is clear that HLA-A and -B locus proteins have similar functions of MHCrestricted antigen recognition; however, the conserved intralocus differences in structure may also indicate that these molecules have some different functions. This possibility is supported by the recent findings (9, 20) that mAb 131 and 4E have different effects on the lyric activity and interleukin 2-dependent proliferation of some human NK clones. If these findings can be extended, it will become an important issue to identify the structural features of HLA-A and -B locus proteins that correlate with their differences in function.
Summary
We describe here a monoclonal antibody, 131, which appears to recognize a determinant shared by HLA-A locus-encoded gene products. Isoelectric focusing analysis demonstrates that 131 reacts with the products of at least seven different HLA-A alleles but none of the five HLA-B allelic products tested. Together with evidence provided by other studies, this finding indicates the existence of A-unique and B-unique determinants, which may have different biological functions. Monoclonal antibody probes, such as the one described here, specific for shared intralocus determinants, may be valuable for assessing these possible functional differences.
